Stanford Uses Data Analytics To Track Off-Label Rx Use
A research team from Stanford University recently compiled a list of 403 distinct off-label drug uses to help determine which medications merited further clinical trials and potential additional FDA approvals. The team used de-identified medication data from the Stanford Translational Research Integrated Data Environment, which includes two million patients treated at the university's health system over the past decade.
- "EHR Notes, Data Analytics Help Track Off-Label Drug Use" (Bresnick, EHR Intelligence, 2/21).